Skip to main content

Article Filters

Clear Filters
Finish

Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK & Singapore

Published date: 15 September 2021

Back to Article Listing

Cambridge, UK – September 15, 2021 – Astrea Bioseparations, a leading provider of bioseparations products and services, today announced two new investments to enhance operations and customer support resources. The investments include an expansion of the company’s research and development facility in Cambridge, United Kingdom to add two new state-of-the-art laboratories. Separately, a branch office was registered in Singapore to serve customers in Asia with Claire Dacombe, PhD appointed as Vice President of Asia Pacific Operations.

“The Cambridge laboratory expansion was a first step in bolstering capacity to meet growing demand for Astrea Bioseparations products and services. New dedicated column packing space was constructed to increase capacity for pre-packed column development and support,” said Dr Steve Burton, President & CSO at Astrea. “A new Biosafety Level 2 (BSL-2) laboratory has facilitated work with pathogenic materials of relevance for viral vector, virus and prion projects. Pursuant to the December 2020 license agreement with AVACTA, we have also dedicated new laboratory space for Affimer® ligand discovery and development work.”

“This is an exciting time as we continue to evolve our commercial strategy with a focus on reliability of supply and quality of products and services. With market demand increasing in Asia, it became clear that it would benefit our customers to have a local presence in Singapore,” Gabe Longoria, CCO said. “We are thrilled to have Claire Dacombe join Astrea Bioseparations with extensive expertise in high level distribution, sales, and operations activities across the Asia Pacific region.”

The team from Astrea Bioseparations invites attendees of Bioprocess International to visit booth 334 in Boston, MA from 21 to 30 September. Or to learn more from any place, visit https://www.astreabioseparations.com or view a new introduction video here.

About Astrea Bioseparations

Astrea Bioseparations Ltd. is a leading provider of bioseparation products and services including catalogue and bespoke chromatography adsorbents, adsorbent discovery and development services, pre-packed chromatography columns and column hardware. The company is headquartered in Cambridge, UK with manufacturing facilities at the Isle of Man, British Isles, Joliette, Quebec and Stoughton, Massachusetts.

Learn more at www.astreabioseparations.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Hannah Ingram
Head of Marketing
h.ingram@astrea-bio.com
+44 (0)1223 736 983

Your basket

Your basket is empty. Continue shopping to add products to your basket.

Your quote list

Your quote list is empty. Continue browsing to add products to your quote list.

Search our catalogue

Call Centre

Request Quote

View Content

Please complete the form below to receive the requested content from Astrea Bioseparations. We will use the data you provide to send you relevant updates, special offers, and product-related information. See our Privacy Notice for details on how we use personal data.

If you have an account please log in to gain access to content. You can apply for an account here

Please enter a First Name

Please enter a valid First Name, the maximum length is 50 characters.

Please enter a Last Name

Please enter a valid Last Name, the maximum length is 50 characters.

Please enter a Company Name

Please enter a valid Company, the maximum length is 100 characters

Please enter a valid Email AddressPlease enter a valid Email AddressThe Email Address entered is already registered, please sign in with the Email Address or enter a different one

Please select a valid Telephone Number, the maximum length is 30 characters

Please enter a valid Telephone Number consisting only of the following characters and spaces ( ) + 0 1 2 3 4 5 6 7 8 9

Please select a State / Province / Territory

Please select a valid State / Province / Territory, the maximum length is 150 characters

Please select a Country

Data entered into form will be stored in your session (not in a cookie) to avoid having to re-enter in future form submissions.

Stock Up & Save on Chromatography Resins - Learn More
  • Home
  • |
  • News and Events
  • |
  • News
  • |
  • Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK & Singapore

Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK & Singapore

Published date: 15 September 2021

Back to Article Listing

Cambridge, UK – September 15, 2021 – Astrea Bioseparations, a leading provider of bioseparations products and services, today announced two new investments to enhance operations and customer support resources. The investments include an expansion of the company’s research and development facility in Cambridge, United Kingdom to add two new state-of-the-art laboratories. Separately, a branch office was registered in Singapore to serve customers in Asia with Claire Dacombe, PhD appointed as Vice President of Asia Pacific Operations.

“The Cambridge laboratory expansion was a first step in bolstering capacity to meet growing demand for Astrea Bioseparations products and services. New dedicated column packing space was constructed to increase capacity for pre-packed column development and support,” said Dr Steve Burton, President & CSO at Astrea. “A new Biosafety Level 2 (BSL-2) laboratory has facilitated work with pathogenic materials of relevance for viral vector, virus and prion projects. Pursuant to the December 2020 license agreement with AVACTA, we have also dedicated new laboratory space for Affimer® ligand discovery and development work.”

“This is an exciting time as we continue to evolve our commercial strategy with a focus on reliability of supply and quality of products and services. With market demand increasing in Asia, it became clear that it would benefit our customers to have a local presence in Singapore,” Gabe Longoria, CCO said. “We are thrilled to have Claire Dacombe join Astrea Bioseparations with extensive expertise in high level distribution, sales, and operations activities across the Asia Pacific region.”

The team from Astrea Bioseparations invites attendees of Bioprocess International to visit booth 334 in Boston, MA from 21 to 30 September. Or to learn more from any place, visit https://www.astreabioseparations.com or view a new introduction video here.

About Astrea Bioseparations

Astrea Bioseparations Ltd. is a leading provider of bioseparation products and services including catalogue and bespoke chromatography adsorbents, adsorbent discovery and development services, pre-packed chromatography columns and column hardware. The company is headquartered in Cambridge, UK with manufacturing facilities at the Isle of Man, British Isles, Joliette, Quebec and Stoughton, Massachusetts.

Learn more at www.astreabioseparations.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Hannah Ingram
Head of Marketing
h.ingram@astrea-bio.com
+44 (0)1223 736 983

Call Centre Product Compare